HeartSciences (HSCS) is scheduled to report Q3 earnings on March 24, 2026. Analysts estimate EPS of $-1.12 and quarterly revenue of $200.00K.

In the most recent quarter (Q2), HeartSciences reported EPS of $-0.85, beating estimates of $-1.12 by 0.24%. Revenue came in at $2.42K, missing the estimate of $50.00K by 0.95%.

HeartSciences has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, HeartSciences has averaged an EPS surprise of 0.23% and a revenue surprise of 0.98%.